The 2020 ISPE Biotechnology Virtual Conference delivered engaging presentations on cutting-edge topics with many opportunities to gain insights from top industry professionals. Check out the content below to get insights from the conference.
The 2020 ISPE Biotechnology Virtual Conference kicked off with keynote speaker Francesco Cicirello, Associate Director, Quality, Adaptimmune, discussing regulations for biologics related to Annex 2 and Part IV EC GMP Guide. In this clip from the closing Q&A, Francesco offers his industry outlook on what would be the potential interference between PIC/S and EC GMP.
In this clip from the 2020 ISPE Biotechnology Virtual Conference session “Regulatory and Quality Considerations for mRNA-based Medicinal Products,” Andreas Kuhn, BioNTech SE, shared a brief look at the status of their COVID-19 vaccine program.
Programme committee member Christoph Herwig, PhD, Professor, Technische Universität Wien, poses this question during a panel discussion with speakers in Track 3: Process and Data Science at the 2020 ISPE Biotechnology Virtual Conference. Watch this clip to hear thoughts from Aspoeck Andreas, Senior Director External Manufacturing, HOOKIPA Pharma Inc.
Watch this clip to hear thoughts from Ralf Pörtner, Senior Research Associate, Hamburg University of Technology, Institute of Bioprocess & Biosystems Engineering, during the 2020 ISPE Biotechnology Virtual Conference session “Model-Assisted Design, Transfer and Scale-Up of an Antibody-Producing Cell Culture Process.”
In this clip from the 2020 ISPE Biotechnology Virtual Conference, Simone Schopf, Group Manager Biotechnological Processes, Fraunhofer FEP, Organic Electronics, Electronic Beam and Plasma Technology, shares examples of how you can use accelerated electrons for the sterilization of surfaces during her keynote presentation “How to Develop Vaccines in Fast Track Development.”
Watch Now: Tania Pereira Chilima, Deputy Chief Technology Officer, Univercells Technologies gives us a look at NevoLine, a system for cost-effective Polio vaccine production, during her presentation “Intensifying Vaccine Manufacture for Rapid Response to Disease Outbreaks” at the 2020 ISPE Biotechnology Virtual Conference.